Worldwide Enteral Nutrition Industry to 2027 - Growth in Incidence of Chronic Diseases is Driving the Market - ResearchAndMarkets.com

The "Enteral Nutrition Market by Protein Composition, Form, Age Group and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.

The global enteral nutrition market was valued at $6,762 million in 2018, and is projected to reach $12,294 million by 2027, registering a CAGR of 7.1% from 2020 to 2027.

Enteral nutrition is prescribed to patients, who are unable to consume sufficient nutrients orally but whose gastrointestinal function is a satisfactory condition for digestion and absorption. This process is deployed when a patient is unable to eat due to some illness, has swallowing difficulties, or surgery that may interfere with the normal eating process. The enteral nutrients are administered directly into the stomach, duodenum, or jejunum of a patient via enteral pumps and enteral feeding tubes. Enteral nutrients are prescribed to patients suffering from chronic illness such as malnutrition, gastrointestinal disorder, cancer, and others. Generally, enteral feeding is deployed in an operation theatre (OT), intensive care unit (ICU), and critical care unit (CCU), and even at home for severely ill patients.

Rise in prevalence of chronic disorders such as cancer and neurological disorders is the major factor that contributes toward the growth of the enteral nutrition market. Other factors that fuel the market growth include increase in geriatric population, and surge in malnutrition cases. Over the years, enteral nutrition is gaining acceptance, owing to the enhancement in techniques, configurations, and ingredients. However, poor demand and lack of awareness of enteral nutrition in underdeveloped countries hamper market growth. Conversely, development of new technologically advanced products and high market potential in untapped emerging economies are expected to provide lucrative opportunities for the growth of the market.

The enteral nutrition market is segmented into protein composition, form, age group, distribution channel, and region. By protein composition, the market is divided into standard protein diet, high protein supplement, protein for diabetes care patient, and others. By form, the market is bifurcated into powder and liquid. By age group, the market is bifurcated into adults (above 18) and pediatric (below 18). By distribution channel, the market is classified into hospital sales, retail, and online. By region, the enteral nutrition market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2018 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of four regions is provided to determine the existing opportunities.
• Profiles and growth strategies of key players are thoroughly analyzed to understand the competitive outlook of the global market.

Market Dynamics

Drivers

• Growth in incidence of chronic diseases
• Rapid growth in geriatric population
• Rise in number of malnutrition cases
• High adoption of enteral nutrition over parenteral nutrition

Restraint

• Poor demand in underdeveloped countries

Opportunities

• Growth opportunities in emerging markets

Key Players Profiled

• Abbott Laboratories
• B. Braun Melsungen AG
• Danone S.A.
• Fresenius Kabi AG
• Global Health Products, Inc.
• Hormel Foods Corporation
• Meiji Holdings Co., Ltd.
• Nestle S.A.
• Reckitt Benckinser Group PLC,
• Victus, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/irl0oh

View source version on businesswire.com: https://www.businesswire.com/news/home/20210611005334/en/